by nikki mann | May 24, 2021 | News
Last month, the Onco-Innovation Programme — part of the CRUK Cambridge Centre and managed by our own Dr Rebecca Harris — launched a new rapid response data analysis pump prime call. This exciting new call was designed to seek collaborative project proposals from CRUK...
by nikki mann | Apr 26, 2021 | News
Work at the Milner Therapeutics Institute by Director Tony Kouzarides and Kostas Tzelepis in collaboration with Storm Therapeutics has made a promising step towards developing a new drug for treating acute myeloid leukaemia. In a paper published today in Nature,...
by nikki mann | Mar 1, 2021 | News
We are excited to announce a new collaboration which has been set up through the Milner Therapeutics Consortium to investigate autophagy targets in neurodegeneration. This is the first such project to bring together multiple academic groups across the University and...
by nikki mann | Dec 3, 2020 | News
As we reach the end of what has been the most challenging and difficult year so far, we want to take the time to celebrate the achievements of our Affiliated Companies. Despite challenging times there have been some fantastic updates, and you can explore them using...
by nikki mann | Nov 25, 2020 | News
We are excited to announce that two new pharma partners — Eli Lilly and Company and Bristol Myers Squibb — have joined the Milner Consortium in the past month. Now with ten pharma partners and three academic partners, this has become one of the largest cross-sector...
by nikki mann | Nov 16, 2020 | News
Start Codon, the life science and healthcare business accelerator based in the Milner Therapeutics Institute, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million. The Fund will be used to support Start Codon’s offering to start-ups,...
